FOXM1 predicts disease progression in non-muscle invasive bladder cancer

被引：0
|
作者：
Sebastien Rinaldetti
Ralph Wirtz
Thomas Stefan Worst
Arndt Hartmann
Johannes Breyer
Lars Dyrskjot
Philipp Erben
机构：
[1] University of Heidelberg,Department of Hematology and Oncology, University Medical Centre Mannheim, Medical Faculty Mannheim
[2] Stratifyer Molecular Pathology,Department of Urology, University Medical Centre Mannheim, Medical Faculty Mannheim
[3] University of Heidelberg,Institute of Pathology
[4] University Hospital Erlangen,Department of Urology
[5] University of Regensburg,Department of Molecular Medicine
[6] Aarhus University Hospital,Department of Clinical Medicine
[7] Aarhus University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷
关键词：
Molecular subtypes; FOXM1; Progression-free survival; Biomarker; Bladder cancer; MKI67;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1701 / 1709
页数：8
相关论文
共 50 条
  • [1] FOXM1 predicts disease progression in non-muscle invasive bladder cancer
    Rinaldetti, Sebastien
    Wirtz, Ralph
    Worst, Thomas Stefan
    Hartmann, Arndt
    Breyer, Johannes
    Dyrskjot, Lars
    Erben, Philipp
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (09) : 1701 - 1709
  • [2] E2F1-FOXM1 activation predicts progression of non-muscle invasive bladder cancer
    Kim, Seon-Kyu
    Lee, Se-Ra
    Roh, Yun-Gil
    Song, Bicna
    Park, Kiejung
    Leem, Sun-Hee
    Chu, In-Sun
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Three-gene signature predicts disease progression of non-muscle invasive bladder cancer
    Jeong, Pildu
    Ha, Yun-Sok
    Cho, In-Chang
    Yun, Seok-Joong
    Yoo, Eun Sang
    Kim, Isaac Yi
    Choi, Yung Hyun
    Moon, Sung-Kwon
    Kim, Wun-Jae
    ONCOLOGY LETTERS, 2011, 2 (04) : 679 - 684
  • [4] Molecular predictors of non-muscle invasive bladder cancer progression
    Smal, M.
    Rolevich, A.
    Nikitchenko, N.
    Krasny, S.
    Goncharova, R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 541 - 541
  • [5] Bladder Cancer: A Review of Non-Muscle Invasive Disease
    Sexton, Wade J.
    Wiegand, Lucas R.
    Correa, Jose J.
    Politis, Christos
    Dickinson, Shohreh Iravani
    Kang, Loveleen C.
    CANCER CONTROL, 2010, 17 (04) : 256 - 268
  • [6] Degree of chromosomal abnormalities detected by UroVysion test predicts progression of non-muscle invasive bladder cancer
    Kocsmar, I.
    Pajor, G.
    Sziraki, A.
    Kocsmar, E.
    Gyongyosi, B.
    Szekely, E.
    Kenessey, I.
    Nyirady, P.
    Kiss, A.
    Schaff, Z.
    Riesz, P.
    Lotz, G.
    VIRCHOWS ARCHIV, 2018, 473 : S189 - S189
  • [7] Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer
    Cormio, Antonella
    Busetto, Gian Maria
    Musicco, Clara
    Sanguedolce, Francesca
    Calo, Beppe
    Chirico, Marco
    Falagario, Ugo Giovanni
    Carrieri, Giuseppe
    Piccoli, Claudia
    Cormio, Luigi
    DIAGNOSTICS, 2021, 11 (08)
  • [8] NEUTROPHIL TO LYMPHOCYTE RATIO PREDICTS RECURRENCE OF NON-MUSCLE INVASIVE BLADDER CANCER
    Yuruk, Emrah
    Saitz, Theodore R.
    Gonultas, Serkan
    Serefoglu, Ege Can
    Muslumanoglu, Ahmet Yaser
    JOURNAL OF UROLOGY, 2015, 193 (04): : E295 - E295
  • [9] PROGRESSION TO MUSCLE INVASIVE DISEASE OF G1-2/LOW GRADE NON-MUSCLE INVASIVE BLADDER CANCER: NEVER AT THE FIRST RECURRENCE
    Palou, Juan
    Rodriguez Faba, Oscar
    Maria Gaya, Josep
    Skrobot, Sergio
    Algaba, Ferran
    Novoa, R.
    Esquena, Salvador
    Villavicencio, Humberto
    JOURNAL OF UROLOGY, 2014, 191 (04): : E698 - E699
  • [10] TaT1 (Non-muscle invasive) Bladder Cancer
    Hakenberg, Oliver W.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (07) : 535 - 535
12345